Xiao-Yan Yang
Overview
Explore the profile of Xiao-Yan Yang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
260
Citations
1528
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li F, Lin D, Yang J, Cui X, Yang X
PLoS One
. 2025 Mar;
20(3):e0316279.
PMID: 40029858
Minor ginsenosides exhibit enhanced pharmacological effects in comparison to the major ginsenosides. However, the natural content of minor ginsenosides in plants is typically insufficient to satisfy clinical demand. Therefore, we...
2.
Yang X, Zeng L, Ye S, Zheng L, Gong Y, Wei B
Shanghai Kou Qiang Yi Xue
. 2025 Feb;
33(6):580-585.
PMID: 40007287
Purpose: To investigate the effect and safety of removing dental resin adhesive with ultrafast laser. Methods: Resin adhesive layers were prepared on the surface of extracted teeth and processed with...
3.
Huang M, Zeng Q, Chen D, Yang C, Yang Y, Zhou M, et al.
Acta Haematol
. 2025 Feb;
:1-14.
PMID: 39933493
Abstract： Introduction: Many reports indicate that the occurrence of multiple myeloma (MM) is closely related to inflammation and immunity. Although the survival rates have been gradually improving in recent years,...
4.
Li Z, Gao Y, Zhao C, An R, Wu Y, Huang Z, et al.
PLoS One
. 2025 Jan;
20(1):e0318005.
PMID: 39869626
Oxidative damage, oxidative inflammation, and a range of downstream diseases represent significant threats to human health. The application of natural antioxidants and anti-inflammatory agents can help prevent and mitigate these...
5.
Yang X, Zheng Y, Tuo J, Zhang H, Xu Z
Ibrain
. 2024 Dec;
10(4):542-546.
PMID: 39691423
A 48-year-old female patient was hospitalized for 5 days after a cold. Encephalitis was considered after preliminary history and routine examination, but the patient did not show significant improvement after...
6.
Zhang S, Tan H, Yang S, Yang X, Cui C, Huang J, et al.
Naunyn Schmiedebergs Arch Pharmacol
. 2024 Dec;
PMID: 39680101
This study aimed to evaluate the pharmacokinetics (PK), pharmacodynamics (PD), safety, and tolerability of SHR6508 injection, a new calcimimetic agent, in healthy Chinese subjects following single dose. This study utilized...
7.
Yang X, Shi X, Xiang Y
Acta Derm Venereol
. 2024 Nov;
104:adv42129.
PMID: 39565230
No abstract available.
8.
Yang X, Luo Z, Fang D, Chen Q, Peng N, Fang H, et al.
Langmuir
. 2024 Oct;
40(43):22875-22886.
PMID: 39418176
Chemotherapy (CT) can significantly inhibit tumor growth, metastasis, and recurrence during cancer therapy. People have widely used platinum drugs in cancer treatment. However, as most chemotherapeutic drugs, platinum drugs still...
9.
Zhang Q, Zhu L, Dong X, Yang X, Hou J, Cui H
FEMS Microbiol Lett
. 2024 Sep;
371.
PMID: 39304533
Five halophilic archaeal strains, XH8T, CK5-1T, GDY1T, HW8-1T, and XH21T, were isolated from commercial coarse salt produced in different regions of China. Their 16S rRNA and rpoB' gene sequences indicated...
10.
Yang X, Zhu W, Di-Chen , Peng D, Peng J, Zhou Z, et al.
CNS Neurol Disord Drug Targets
. 2024 Sep;
PMID: 39252618
Introduction: Heme-oxidized iron regulatory protein 2 (IRP2) ubiquitin ligase-1 (HOIL-1) is believed to contribute to the ubiquitination of IRP2, which facilitates the transcription of transferrin receptor 1 (TfR1) while preventing...